journal article·2012-11-14Open access

Mineralization Content Alters Osteogenic Responses of Bone Marrow Stromal Cells on Hydroxyapatite/Polycaprolactone Composite Nanofiber Scaffolds

Timothy Ruckh, Derek Carroll, Justin Weaver, Ketul Popat

Abstract

Synthetic tissue scaffolds have a high potential impact for patients experiencing osteogenesis imperfecta. Using electrospinning, tissue scaffolds composed of hydroxyapatite/polycaprolactone (HAp/PCL) composite nanofibers were fabricated with two different HAp concentrations—1% and 10% of the solid scaffold weight. After physico-chemical scaffold characterization, rat bone marrow stromal cells were cultured on the composite scaffolds in maintenance medium and then in osteogenic medium. Quantitative PCR, colorimetric assays, immunofluorescent labeling, and electron microscopy measured osteogenic cell responses to the HAp/PCL scaffolds. In maintenance conditions, both Hap/PCL scaffolds and control scaffolds supported cell colonization through seven days with minor differences. In osteogenic conditions, the 10% HAp scaffolds exhibited significantly increased ALP assay levels at week 3, consistent with previous reports. However, qPCR analysis demonstrated an overall decrease in bone matrix-associated genes on Hap/PCL scaffolds. Osteopontin and osteocalcin immunofluorescent microscopy revealed a trend that both mineralized scaffolds had greater amounts of both proteins, though qPCR results indicated the opposite trend for osteopontin. Additionally, type I collagen expression decreased on HAp scaffolds. These results indicate that cells are sensitive to minor changes in mineral content within nanofibers, even at just 1% w/w, and elucidating the sensing mechanism may lead to optimized osteogenic scaffold designs.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Bone Tissue Engineering Materials · Bone and Dental Protein Studies · Electrospun Nanofibers in Biomedical Applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

School of Biomedical Engineering, Colorado State University, Fort Collins, CO 80523, USA

Department of Mechanical Engineering, Colorado State University, Fort Collins, CO 80523, USA

Department of Chemical Engineering, Colorado State University, Fort Collins, CO 80523, USA

References (89)

Show source-provided references
1. Tissue engineering for bone defect healing: an update on a multi-component approach10.1016/S0020-1383(08)70011-1 ↗
2. Differentiation of osteoblasts and osteocytes from mesenchymal stem cells10.2174/157488808784223032 ↗
3. Characterization of cells with osteogenic potential from human marrow10.1016/8756-3282(92)90364-3 ↗
4. Marrow stromal cells as stem cells for nonhematopoietic tissues10.1126/science.276.5309.71 ↗
5. Dexamethasone, BMP-2, and 1,25-dihydroxyvitamin D enhance a more differentiated osteoblast phenotype: Validation of an in vitro model for human bone marrow-derived primary osteoblasts10.1016/j.steroids.2003.12.005 ↗
6. Sustained release of BMP-2 in a lipid-based microtube vehicle10.1016/j.actbio.2008.09.001 ↗
7. Laflamme, C., and Rouabhia, M. (2008). Effect of BMP-2 and BMP-7 homodimers and a mixture of BMP-2/BMP-7 homodimers on osteoblast adhesion and growth following culture on a collagen scaffold. Biomed. Mater., 3.10.1088/1748-6041/3/1/015008 ↗
8. Poly(lactide-co-glycolide)/hydroxyapatite delivery of BMP-2-producing cells: A regional gene therapy approach to bone regeneration10.1016/S0142-9612(00)00279-9 ↗
9. Osteoblastic differentiation of human bone marrow stromal cells in self-assembled BMP-2 receptor-binding peptide-amphiphiles10.1016/j.biomaterials.2009.03.018 ↗
10. Integrin alpha2beta1 plays a critical role in osteoblast response to micron-scale surface structure and surface energy of titanium substrates10.1073/pnas.0805420105 ↗
11. The effect of irradiation modification and RGD sequence adsorption on the response of human osteoblasts to polycaprolactone10.1016/j.biomaterials.2004.11.047 ↗
12. The control of human mesenchymal cell differentiation using nanoscale symmetry and disorder10.1038/nmat2013 ↗
13. The use of nanoscale topography to modulate the dynamics of adhesion formation in primary osteoblasts and ERK/MAPK signalling in STRO-1+ enriched skeletal stem cells10.1016/j.biomaterials.2009.05.049 ↗
14. Direct and indirect effects of microstructured titanium substrates on the induction of mesenchymal stem cell differentiation towards the osteoblast lineage10.1016/j.biomaterials.2009.12.029 ↗
15. Ruckh, T.T., Kumar, K., Kipper, M.J., and Popat, K.C. (2010). Osteogenic differentiation of bone marrow stromal cells on poly(epsilon-caprolactone) nanofiber scaffolds. Acta Biomater.10.1016/j.actbio.2010.02.006 ↗
16. Osteoblastic phenotype expression of MC3T3-E1 cultured on electrospun polycaprolactone fiber mats filled with hydroxyapatite nanoparticles10.1021/bm700451p ↗
17. Zhang, P., Hong, Z., Yu, T., Chen, X., and Jing, X. (2008). In vivo mineralization and osteogenesis of nanocomposite scaffold of poly(lactide-co-glycolide) and hydroxyapatite surface-grafted with poly(l-lactide). Biomaterials.10.1016/j.biomaterials.2008.08.041 ↗
18. Control of osteogenic differentiation and mineralization of human mesenchymal stem cells on composite nanofibers containing poly[lactic-co-(glycolic acid)] and hydroxyapatite10.1002/mabi.200900169 ↗
19. Nanostructured biocomposite substrates by electrospinning and electrospraying for the mineralization of osteoblasts10.1016/j.biomaterials.2008.12.079 ↗
20. Ramakrishna, S., Fujihara, K., Teo, W.-E., Lim, T.-C., and Ma, Z. (2005). An Introduction to Electrospinning and Nanofibers, World Scientific.10.1142/9789812567611 ↗
21. Formation of fibers by electrospinning10.1016/j.addr.2007.04.020 ↗
22. Experimental investigation of the governing parameters in the electrospinning of polymer solutions10.1016/j.polymer.2004.01.024 ↗
23. Poly-e-caprolactone microspheres and nanospheres: An overview10.1016/j.ijpharm.2004.01.044 ↗
24. Biodegradable electrospun fibers for drug delivery10.1016/S0168-3659(03)00372-9 ↗
25. Effects of block length on the enzymatic degradation and erosion of oxazoline linked poly-e-caprolactone10.1016/j.ejps.2007.03.001 ↗
26. In vitro biocompatibility of schwann cells on surfaces of biocompatible polymeric electrospun fibrous and solution-cast film scaffolds10.1021/bm061152a ↗
27. Biomimetic systems for hydroxyapatite mineralization inspired by bone and enamel10.1021/cr8004422 ↗
28. Impaired calcification around matrix vesicles of growth plate and bone in alkaline phosphatase-deficient mice10.1016/S0002-9440(10)63172-0 ↗
29. In vitro modeling of matrix vesicle nucleation: Synergistic stimulation of mineral formation by annexin A5 and phosphatidylserine10.1074/jbc.M701057200 ↗
30. Hierarchical modeling of the elastic properties of bone at submicron scales: The role of extrafibrillar mineralization10.1529/biophysj.107.125567 ↗
31. Micromechanical properties of human trabecular bone: A hierarchical investigation using nanoindentation10.1002/jbm.a.31766 ↗
32. Hierarchical structure of bone and micro-computed tomography10.1007/978-1-4615-0651-5_8 ↗
33. The collagen receptor subfamily of the integrins10.1016/j.biocel.2003.08.016 ↗
34. Osteopontin expression and function: Role in bone remodeling10.1002/(SICI)1097-4644(1998)72:30/31+<92::AID-JCB13>3.0.CO;2-A ↗
35. Control of osteopontin signaling and function by post-translational phosphorylation and protein folding10.1002/jcb.21558 ↗
36. Osteopontin: An interfacial extracellular matrix protein in mineralized tissues10.3109/03008209609029192 ↗
37. In situ growth of hydroxyapatite within electrospun poly(DL-lactide) fibers10.1002/jbm.a.31187 ↗
38. Proliferation and osteoblastic differentiation of human bone marrow stromal cells on hydroxyapatite/bacterial cellulose nanocomposite scaffolds10.1089/ten.tea.2008.0110 ↗
39. The influence of hydroxyapatite particles on in vitro degradation behaviour of pcl based composite scaffolds10.1089/ten.tea.2008.0543 ↗
40. Improved biological characteristics of poly(L-lactic acid) electrospun membrane by incorporation of multiwalled carbon nanotubes/hydroxyapatite nanoparticles10.1021/bm7006295 ↗
41. Nanobioengineered electrospun composite nanofibers and osteoblasts for bone regeneration10.1111/j.1525-1594.2008.00557.x ↗
42. Electrospinning biomedical nanocomposite fibers of hydroxyapaite/poly(lactic acid) for bone regeneration10.1002/jbm.a.30866 ↗
43. Peroxisome proliferator-activated receptor activators modulate the osteoblastic maturation of MC3T3-E1 preosteoblasts10.1016/S0014-5793(00)01372-7 ↗
44. The peroxisome proliferator activator receptor alpha/delta agonists linoleic acid and bezafibrate upregulate osteoblast differentiation and induce periosteal bone formation in vivo10.1007/s00223-008-9175-9 ↗
45. Molecular recognition of fatty acids by peroxisome proliferator-activated receptors10.1016/S1097-2765(00)80467-0 ↗
46. The mechanisms of action of PPARs10.1146/annurev.med.53.082901.104018 ↗
47. Lecka-Czernik, B., and Suva, L.J. (2006). Resolving the two “bony” faces of PPAR-gamma. PPAR Res.10.1155/PPAR/2006/18089 ↗
48. PPARg inhibits osteogenesis via the down-regulation of the expression of COX-2 and iNOS in rats10.1016/j.bone.2007.06.017 ↗
49. PPAR-Alpha agonists increase bone mineral density in female rats
50. Identification of novel regulators associated with early-phase osteoblast differentiation10.1359/JBMR.040216 ↗
51. Effect of fiber diameter on spreading, proliferation, and differentiation of osteoblastic cells on electrospun poly(lactic acid) substrates10.1016/j.biomaterials.2005.05.084 ↗
52. Effect of fiber diameter and orientation on fibroblast morphology and proliferation on electrospun poly(D,L-lactic-co-glycolic acid) meshes10.1016/j.biomaterials.2006.07.005 ↗
53. Molecular aspects of fracture healing: Which are the important molecules?10.1016/j.injury.2007.02.006 ↗
54. Insulin-like growth factor 2 (IGF2) potentiates BMP9-induced osteogenic differentiation and bone formation10.1002/jbmr.133 ↗
55. Stem cell- and scaffold-based tissue engineering approaches to osteochondral regenerative medicine10.1016/j.semcdb.2009.03.017 ↗
56. Expression of extracellular matrix genes: transforming growth factor (TGF)-beta1 and ras in tibial fracture healing of lathyritic rats10.1016/S8756-3282(00)00359-8 ↗
57. Localization of the mRNA for bone matrix proteins during fracture healing as determined by in situ hybridization10.1002/jbmr.5650091007 ↗
58. Mandibular defect reconstruction using three-dimensional polycaprolactone scaffold in combination with platelet-rich plasma and recombinant human bone morphogenetic protein-2: De novo synthesis of bone in a single case10.1089/ten.tea.2008.0033 ↗
59. Expression of bone matrix proteins during de novo bone formation using a bovine collagen and platelet-rich plasma (prp)—an immunohistochemical analysis10.1016/j.biomaterials.2004.07.041 ↗
60. Impaired bone fracture healing in matrix metalloproteinase-13 deficient mice10.1016/j.bbrc.2006.12.234 ↗
61. Systemic regulation of angiogenesis and matrix degradation in bone regeneration—distraction osteogenesis compared to rigid fracture healing10.1016/j.bone.2005.06.014 ↗
62. Matrix metalloproteinases and failed fracture healing10.1016/j.bone.2005.06.015 ↗
63. Structure and mechanism of alkaline phosphatase10.1146/annurev.bb.21.060192.002301 ↗
64. The role of tissue-nonspecific alkaline phosphatase in the phosphate-induced activation of alkaline phosphatase and mineralization in SaOS-2 human osteoblast-like cells10.1007/s11010-008-9788-3 ↗
65. Kulterer, B., Friedl, G., Jandrositz, A., Sanchez-Cabo, F., Prokesch, A., Paar, C., Scheideler, M., Windhager, R., Preisegger, K.H., and Trajanoski, Z. (2007). Gene expression profiling of human mesenchymal stem cells derived from bone marrow during expansion and osteoblast differentiation. BMC Genomics., 8.10.1186/1471-2164-8-70 ↗
66. Effect of hydroxyapatite-coated nanofibrous membrane on the responses of human periodontal ligament fibroblast10.2109/jcersj2.116.31 ↗
67. Electrospun-modified nanofibrous scaffolds for the mineralization of osteoblast cells
68. Protein kinases of cultured osteoblasts: Selectivity for the extracellular matrix proteins of bone and their catalytic competence for osteopontin10.1002/jbmr.5650111013 ↗
69. Casein kinase 2 phosphorylation of recombinant rat osteopontin enhances adhesion of osteoclasts but not osteoblasts10.1002/(SICI)1097-4652(199807)176:1<179::AID-JCP19>3.0.CO;2-2 ↗
70. Expression of bone microsomal casein kinase II, bone sialoprotein, and osteopontin during the repair of calvarial defects10.1016/S8756-3282(98)00057-X ↗
71. Global amplification polymerase chain reaction reveals novel transitional stages during osteoprogenitor differentiation10.1242/jcs.00376 ↗
72. Spatial distribution of mineralized bone matrix produced by marrow mesenchymal stem cells in self-assembling peptide hydrogel scaffold10.1002/jbm.a.31439 ↗
73. Structure and molecular regulation of bone matrix proteins10.1002/jbmr.5650081310 ↗
74. Bone matrix proteins: Their function, regulation, and relationship to osteoporosis10.1007/s00198-002-1342-7 ↗
75. Post-translational modifications of sibling proteins and their roles in osteogenesis and dentinogenesis10.1177/154411130401500302 ↗
76. Comprehensive identification of post-translational modifications of rat bone osteopontin by mass spectrometry10.1021/bi050109p ↗
77. The inhibitory activity of osteopontin on hydroxyapatite formation in vitro10.1111/j.1749-6632.1995.tb44642.x ↗
78. Inhibition of hydroxyapatite formation by osteopontin phosphopeptides10.1042/bj20031150 ↗
79. The influence of surface mineral and osteopontin on the formation and function of murine bone marrow-derived osteoclasts10.1007/s10856-008-3455-9 ↗
80. Novel functions of the matricellular proteins osteopontin and osteonectin/SPARC10.1080/03008200290001050 ↗
81. Specific adsorption of osteopontin and synthetic polypeptides to calcium oxalate monohydrate crystals10.1529/biophysj.106.101881 ↗
82. Cell shape, cytoskeletal tension, and RhoA regulate stem cell lineage commitment10.1016/S1534-5807(04)00075-9 ↗
83. RhoA and cytoskeletal disruption mediate reduced osteoblastogenesis and enhanced adipogenesis of human mesenchymal stem cells in modeled microgravity10.1359/JBMR.050611 ↗
84. ECM compliance regulates osteogenesis by influencing MAPK signaling downstream of RhoA and ROCK10.1359/jbmr.081240 ↗
85. The small GTPase RhoA is crucial for MC3T3-E1 osteoblastic cell survival10.1002/jcb.22059 ↗
86. A novel regulatory mechanism of the bone morphogenetic protein (BMP) signaling pathway involving the carboxyl-terminal tail domain of BMP type II receptor10.1128/MCB.00218-07 ↗
87. On the road to understanding of the osteoblast adhesion: Cytoskeleton organization is rearranged by distinct signaling pathways10.1002/jcb.22236 ↗
88. Biomechanical and molecular regulation of bone remodeling10.1146/annurev.bioeng.8.061505.095721 ↗
89. Improved ethanol precipitation of DNA10.1002/elps.200900721 ↗